Companies in the oncology sector developing innovative solutions and technologies.
Explore 295 recently funded oncology companies with verified founder contact information and fundraising data.
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Quantum Surgical mission is to democratize minimally invasive liver cancer treatment
ALERCELL AI-powered epigenetic diagnostic platform detecting leukemia up to 41 months before clinical symptoms.
Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.
MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.
Crossbow Therapeutics is a biotech company that develops targeted therapies to address cancer antigens.
Probmet is a precision oncology therapeutics company developing treatments for cancer.
Medisprof offers oncology services with diagnostics, personalized treatment, and care in Cluj-Napoca, Romania.
Pegasi is a health tech company that uses AI & clinical data integration for risk analysis and treatment monitoring of cancer patients.
Avenda Health brings superhuman abilities to cancer surgeons and oncologists using AI
Aida uses machine learning and gene expression of individual tumors to help clinicians to prescribe the best drugs for each cancer patient.
ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.
Luminary Therapeutic is a cancer research center that develops pre-clinical stage cell therapy for cancer and autoimmune diseases.
Prokarium is biopharmaceutical company leading the oncology field of microbial immunotherapy.
Ancora.ai is an AI-enabled, digital clinical trial recruitment platform connecting patients to clinical trials.
Stephenson Cancer Center is a non-profit organization that offers cancer treatment, innovative research and extensive clinical trials.
Nodus Oncology Developing the DDR targeting therapies.
Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.
Resolute is advancing a first-in-class platform of cytotoxics and radiotherapeutics for aggressive and hard to treat solid tumors.
2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.
Avitia improves cancer treatment via advanced molecular testing solutions, offers testing tools for use onsite, bioinformatics driven by AI.
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 295 oncology companies tracked in the VCBacked database.
Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked